EPo

Erythropoietin (EPO) is a glycoprotein hormone primarily produced by the kidneys that plays a crucial role in the regulation of red blood cell (RBC) production. In preclinical research, EPO is widely studied for its erythropoietic, neuroprotective, and tissue oxygenation properties. Its ability to stimulate erythropoiesis makes it a central molecule in studies involving hypoxia, endurance, and anemia models.

Benefits (Based on Preclinical Research):

• Stimulates bone marrow activity to produce red blood cells

• Enhances oxygen delivery to tissues and muscles

• Studied for neuroprotective effects in models of brain injury and stroke

• Supports wound healing and tissue recovery under hypoxic conditions

• May improve endurance and performance in hypoxia research models

Who Uses This:

Used in hematology, neurobiology, sports science, and regenerative medicine research to investigate responses to low-oxygen environments, blood cell regeneration, and neural protection.

Why Choose EPO:

• Bioactive recombinant erythropoietin form

• Supplied in sterile, lyophilized format for precise dosing

• Verified via HPLC and Mass Spectrometry

• Provided with Certificate of Analysis (COA)

• Ideal for both in vitro and in vivo models of oxygen regulation

Documentation and Quality:

Each vial is vacuum-sealed and stored under cold-chain conditions. Batch-specific COA and lab-grade handling instructions are included for reliable research use.

Disclaimer:

For research use only. Not intended for human administration or therapeutic application. To be handled strictly by qualified laboratory professionals in controlled settings.